Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma — Stella

Home/Peripheral T-cell Lymphomas/Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

View on ClinicalTrials.gov

Recruiting

Back to Peripheral T-cell Lymphomas trials

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

National Institutes of Health Clinical Center, Bethesda, Maryland

National Marrow Donor Program, Minneapolis, Minnesota

Key details

Phase

Safety & dosing

Sponsor

National Cancer Institute (NCI)

Enrollment target

~330 participants

Started

April 2019

Primary completion

October 2026

Age range

12 Years – 120 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.